For example, the increased expression of CD200 and galectin-9 on cancer cells (ligands of CD200R and TIM-3 on NK cells, respectively) has been demonstrated in acute myeloid leukemia (AML) [48, 49]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.